-
My Account
My Account
BSE Live
Apr 16, 16:00Prev. Close
436.35
Open Price
435.25
Bid Price (Qty.)
444.50 (50)
Offer Price (Qty.)
446.15 (1826)
NSE Live
Apr 16, 15:59Prev. Close
436.50
Open Price
434.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
446.50 (10835)
| Balance Sheet of Laurus Labs (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 106.91 | 106.44 | 106.03 | 105.76 | 15.77 | |
| Total Share Capital | 106.91 | 106.44 | 106.03 | 105.76 | 82.38 | |
| Reserves and Surplus | 1,708.89 | 1,484.46 | 1,407.27 | 1,249.82 | 785.02 | |
| Total Reserves and Surplus | 1,708.89 | 1,484.46 | 1,407.27 | 1,249.82 | 785.02 | |
| Total Shareholders Funds | 1,815.80 | 1,590.90 | 1,513.30 | 1,355.58 | 934.01 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 165.00 | 258.66 | 141.66 | 122.39 | 460.63 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 44.78 | |
| Other Long Term Liabilities | 77.30 | 60.12 | 64.70 | 63.07 | 44.16 | |
| Long Term Provisions | 44.53 | 29.22 | 20.10 | 14.17 | 6.77 | |
| Total Non-Current Liabilities | 286.84 | 348.00 | 226.46 | 199.63 | 556.33 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 762.44 | 657.68 | 726.06 | 615.06 | 468.22 | |
| Trade Payables | 603.54 | 477.40 | 306.81 | 298.80 | 252.49 | |
| Other Current Liabilities | 259.82 | 237.90 | 230.70 | 198.81 | 144.32 | |
| Short Term Provisions | 10.91 | 6.45 | 4.46 | 4.68 | 19.60 | |
| Total Current Liabilities | 1,636.72 | 1,379.44 | 1,268.02 | 1,117.34 | 884.62 | |
| Total Capital And Liabilities | 3,739.36 | 3,318.33 | 3,007.77 | 2,672.55 | 2,308.35 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 1,684.44 | 1,586.87 | 1,440.55 | 1,186.01 | 1,072.19 | |
| Intangible Assets | 9.74 | 12.12 | 7.14 | 7.24 | 6.39 | |
| Capital Work-In-Progress | 66.53 | 107.15 | 163.18 | 143.26 | 69.60 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 1,760.70 | 1,706.14 | 1,610.87 | 1,336.51 | 1,148.17 | |
| Non-Current Investments | 58.32 | 58.32 | 51.74 | 50.53 | 26.12 | |
| Deferred Tax Assets [Net] | 69.76 | 48.91 | 48.65 | 63.46 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 127.68 | |
| Other Non-Current Assets | 65.94 | 71.17 | 67.35 | 65.74 | 9.04 | |
| Total Non-Current Assets | 1,954.71 | 1,884.52 | 1,778.61 | 1,516.24 | 1,311.02 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 893.47 | 665.91 | 575.78 | 501.21 | 487.09 | |
| Trade Receivables | 778.04 | 686.64 | 555.14 | 561.96 | 443.70 | |
| Cash And Cash Equivalents | 0.93 | 0.57 | 0.92 | 2.42 | 23.88 | |
| Short Term Loans And Advances | 0.49 | 0.42 | 0.83 | 0.28 | 29.43 | |
| OtherCurrentAssets | 111.72 | 80.28 | 96.51 | 90.45 | 13.23 | |
| Total Current Assets | 1,784.65 | 1,433.81 | 1,229.16 | 1,156.31 | 997.33 | |
| Total Assets | 3,739.36 | 3,318.33 | 3,007.77 | 2,672.55 | 2,308.35 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 342.92 | 199.62 | 207.49 | 188.62 | 184.92 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 793.87 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 30.24 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 990.90 | 1,156.10 | 872.30 | 856.00 | 35.81 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | 1,929.90 | 786.00 | 2,039.30 | 674.50 | 650.11 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 73.97 | 73.97 | 73.97 | 73.97 | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 58.32 | 58.32 | 3.41 | 3.41 | 26.12 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
29.01.2021
Laurus Labs Standalone December 2020 Net Sales at Rs 1,272.27 crore, up 76.46% Y-o-Y
02.11.2020
Laurus Labs Standalone September 2020 Net Sales at Rs 1,127.30 crore, up 59.71% Y-o-Y
30.10.2020
Laurus Labs Standalone September 2020 Net Sales at Rs 1,127.30 crore, up 59.71% Y-o-Y
31.07.2020
Laurus Labs Standalone June 2020 Net Sales at Rs 970.41 crore, up 79.29% Y-o-Y
12.04.2021
Laurus Labs Q4 PAT seen up 366.3% YoY to Rs. 232.2 cr: Sharekhan
18.01.2019
Laurus Labs Q3 PAT may dip 48.3% YoY to Rs. 17.8 cr: Sharekhan
17.10.2018
Laurus Labs Q2 PAT may dip 46.7% YoY to Rs. 30 cr: HDFC Securities
17.10.2018
Laurus Labs Q2 PAT may dip 49.4% YoY to Rs. 24.5 cr: Sharekhan
